Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07521059 · ClinicalTrials.gov registry record · NA
Short-Term Safety of Low-Dose Creatine Hydrochloride: A 28-Day Single-Arm Pilot Study
A NA study, sponsored by Vireo Systems.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT07521059 is a NA study that has completed, run by Vireo Systems. The registered enrollment target is 11 participants.
The verdict
NCT07521059, a NA study, has completed, sponsored by Vireo Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Background: Creatine monohydrate (typically 5-20 g/day) has a well-established safety profile across diverse populations. Creatine hydrochloride (CR-HCl) is a highly soluble creatine formulation that may allow effective supplementation at substantially lower doses (750 mg - 3 g/day); however, controlled human safety data specific to CR-HCl remain limited. Objective: To evaluate the short-term laboratory safety and tolerability of low-dose CR-HCl supplementation administered for 28 days in healthy adults.
Interventions
- DIETARY_SUPPLEMENT creatine supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-05-30 |
| Est. Completion | 2024-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07521059
The ClinicalTrials.gov registry entry for NCT07521059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vireo Systems, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which creatine supplementation is the first listed.
NCT07521059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07521059 about?
NCT07521059 is a clinical study titled "Short-Term Safety of Low-Dose Creatine Hydrochloride: A 28-Day Single-Arm Pilot Study". Background: Creatine monohydrate (typically 5-20 g/day) has a well-established safety profile across diverse populations. Creatine hydrochloride (CR-HCl) is a highly soluble creatine formulation that may allow effective supplementation at substantially lower doses (750 mg - 3 g/day); however, contro...
What is the current status of trial NCT07521059?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2024-05-30. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT07521059?
The interventions under investigation include: creatine supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07521059?
This trial is sponsored by Vireo Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.